3.3 Effect of use of ACEi/ARB in patients with COVID-19 on risk of hospitalisation
There was a statistically non-significant 19% (95% CI: 0.42-1.55, I2: 0.000) reduction in the odds of risk of hospitalisation in the patients on ACEi/ARB compared to those not on ACEi/ARB. There was negligible heterogeneity. (Figure 5)